Skip to main content

Windward Bio Group AG

WWB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002145089

In the last 90 days, Windward Bio Group AG insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysLast 90 days, $49.8M in total
2
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026
0
13F valueReported value at the end of Q3 2026
$0
Superinvestors holdingAt the end of Q3 2026
0

Price chart

Superinvestors holding WWB, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding WWB at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Windward Bio Group AG insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)5:12 PM ETNov 162 daysBonita David PDirector, 10% OwnerPPurchase+1.18M$17.00+$20.0M+221.3%1.71M afterDuplicate filing
Nov 18, 2026 (view filing)5:08 PM ETNov 162 daysOrbiMed Advisors LLC and 1 otherDirector, 10% OwnerPPurchase+1.18M$17.00+$20.0M+221.3%1.71M after
Nov 18, 2026 (view filing)4:30 PM ETNov 162 daysStampacchia OtelloDirectorPPurchase+1.75M$17.00+$29.8MNew position875.0K after2 lots

Top 10 13F holders, Q3 2026

View all: Top 10 13F holders, Q3 2026

The largest institutional positions in Windward Bio Group AG at the end of Q3 2026; share changes are against Q2 2026.

No institution reported holding WWB in 13F filings for Q3 2026.